Studies on the Role of the V3 Loop in Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Function
- 1 September 1992
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 8 (9) , 1611-1618
- https://doi.org/10.1089/aid.1992.8.1611
Abstract
Mutations within the principal neutralizing determinant (the V3 loop) of the HIV-1 surface envelope glycoprotein gp120 block or greatly reduce the ability of the HIV-1 envelope glycoprotein to induce cell fusion in CD4+ HeLa T4 cells while keeping its CD4 binding ability. However, when either cysteine or both cysteines forming the V3 disulfide bridge were mutated, the resultant glycoprotein could not mediate cell fusion, undergo proteolytic processing, or bind CD4. To investigate the role that the V3 loop plays in gp160 processing and CD4 binding, we deleted the entire V3 loop region of the HIV-1 env gene. The resultant glycoprotein could not mediate cell fusion in the HeLa T4 cell line and no proteolytic processing of gp160 or CD4 binding could be detected. To test whether any domain of the V3 loop is involved in attaining the proper envelope glycoprotein conformation required for proteolytic processing and CD4 binding, we introduced a series of deletions into the coding region of the V3 loop. Most of the residues within the V3 loop could be removed while retaining gp160 processing and CD4 binding. Our results indicate that the cysteines that form the V3 loop or the disulfide bond itself are important for proper envelope glycoprotein folding and processing. Because many of the mutants constructed in this study do not contain the type-specific neutralizing determinant of HIV-1, they may be potential reagents to bind group-specific neutralizing antibodies or to elicit a group-specific neutralizing response against HIV-1.Keywords
This publication has 51 references indexed in Scilit:
- Cross-Neutralizing Antibodies in Rabbits Immunized with HIV-1 gp160 Purified from Simian Cells Infected with a Recombinant Vaccinia VirusAIDS Research and Human Retroviruses, 1991
- Identification of Conserved Residues in the Human Immunodeficiency Virus Type 1 Principal Neutralizing Determinant That Are Involved in FusionAIDS Research and Human Retroviruses, 1991
- Cross-Neutralizing Antibodies to HIV-1 in Mice After Immunization with gp160 Iscoms. Dissection of the Immune ResponseAIDS Research and Human Retroviruses, 1991
- Neutralizing Antibodies Against HIV-1 BRU and SF2 Isolates Generated in Mice Immunized with Recombinant Vaccinia Virus Expressing HIV-1 (BRU) Envelope Glycoproteins and Boosted with Homologous gp160AIDS Research and Human Retroviruses, 1991
- A molecular constraint that generates a cis peptide bondJournal of the American Chemical Society, 1991
- Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing DeterminantScience, 1990
- Shedding and Interspecies Type Sero-reactivity of the Envelope Glycopolypeptide gp120 of the Human Immunodeficiency VirusJournal of General Virology, 1986
- The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brainCell, 1986
- Major Glycoprotein Antigens That Induce Antibodies in AIDS Patients Are Encoded by HTLV-IIIScience, 1985
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984